Spotlight Medical Emerges from Stealth to Tackle the Critical Issue of Inadequate Cancer Treatments

Founded by a physician, an AI researcher, and an entrepreneur, Spotlight Medical addresses the critical issue of inadequate cancer treatments. Many patients face over- or undertreatment, leading to reduced survival rates and unnecessary side effects. The founders believe that patient data holds untapped potential, which AI can harness to significantly improve patient care by identifying the most appropriate treatment for each individual.

Spotlight Medical’s clinical AI tests extract meaningful biological information from patient data within a secure and regulated framework. This data predicts treatment response efficacy, guiding oncologists in selecting the most suitable options for their patients. The technology is versatile, capable of handling various cancer types, with the first test focusing on a specific use case to be announced soon.

The strategic alliance between Institut Curie and Spotlight Medical combines clinical expertise, extensive clinical data, advanced technology, and industrial resources to accelerate the development and implementation of innovative cancer solutions.